إعلان مُمول

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
البحث
الأقسام
إقرأ المزيد
Uttarakhand chopper crash: In Cyprus, PM Modi speaks to CM Pushkar Dhami; assures cooperation from Centre
بواسطة BharatUpdates 0 5
Drama! Johnson slams Hazlewood for playing in IPL over national duty: 'We've ...'
Mitchell Johnson has criticised Josh Hazlewood's choice to play in the IPL instead of preparing...
بواسطة BharatUpdates 0 10
IND vs ENG | Like England have Bashir, India should back Kuldeep: Ex-India cricketer
With Ashwin's retirement, Kuldeep Yadav is expected to lead India's spin attack in the upcoming...
بواسطة BharatUpdates 0 10
Torii's Head Chef shares SRK-AbRam’s favorite dish
Torii, Gauri Khan's Mumbai restaurant, is a celebrity hotspot with a secret entrance for the Khan...
بواسطة BharatUpdates 0 12
Madhyabindu Provincial Hospital upgraded to 100-bed facility
NAWALPARASI: Madhyabindu Provincial Hospital, located in Kawasoti-16, Danda of Nawalparasi...
بواسطة HamroGlobal 0 14